超越遗传学:综合性瘤学和癌症治疗的代谢视角
Pradeep Mk Nair1, Karishma Silwal2, Renganathan Ramalakshmi1
1Department of Integrative Oncology, Mirakle Integrated Health Centre, Pollachi, India.
Frontiers in oncology
|October 8, 2024
概括
综合性瘤学将癌症视为一种代谢性疾病,而不仅仅是遗传性疾病. 这种方法使用整体疗法来纠正代谢失衡,通过整合遗传和代谢视角来改善患者的结果和经验.
科学领域:
- 在瘤学瘤学.
- 代谢医学是一种代谢医学.
- 综合医学是一个整体的医学.
背景情况:
- 癌症传统上被视为遗传性疾病,常规疗法如化疗和免疫疗法改善了生存率.
- 越来越需要将癌症视为一种代谢性疾病,以提高患者的护理.
- 综合性瘤学结合了整体疗法,以解决癌症中的代谢失调问题.
研究的目的:
- 提供综合医学在治疗癌症代谢方面的证据和策略的概述.
- 突出结合癌症的遗传和代谢理论的重要性.
- 促进整体的,以患者为中心的整合性瘤学的方法.
主要方法:
- 审查支持综合医学在癌症代谢中的方法的证据.
- 对针对与癌症相关的代谢失衡的整体治疗方法的分析.
- 讨论包括酸性微环境,维生素C缺乏和线粒体功能障碍在内的因素.
主要成果:
- 综合医学提供了纠正癌症代谢失衡的策略.
- 解决诸如氧化应激和功能障碍自等因素至关重要.
- 整合遗传和代谢观点可以改善患者的治疗结果.
结论:
- 将癌症视为一种代谢性疾病对于全面的瘤治疗至关重要.
- 综合性瘤学,通过结合遗传和代谢的观点,提供了一个更全面和以患者为中心的治疗方法.
- 这种综合方法旨在改善患者的结果和体验.
相关概念视频
02:50Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
02:49Cancer Therapies
7.6K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.6K
01:27Tumor Immunotherapy
489
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
489
02:57Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
02:30Metastasis
5.5K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.5K
02:17The Tumor Microenvironment
6.6K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.6K